BTAIVSISPC• 3 Months (Normalized)
BTAI vs ISPC (BioXcel Therapeutics Inc. vs iSpecimen Inc.)
Showing Closing Date Range from Jun, 16 to Sep, 14, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BTAI Performance $0.05
-96.24%
BioXcel Therapeutics Inc.
Normalized Baseline0.00%
ISPC Performance $1.47
-44.11%
iSpecimen Inc.
Normalized Baseline0.00%
Alpha Spread Margin ISPC LEADS
-52.13%
ISPC outperforming by 52.13%
BTAIISPC
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BTAI ISPC
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(62 dates)
| Date | BTAI Price | BTAI Gain (%) | ISPC Price | ISPC Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 14, 2026 | $0.05 | -96.24% | $1.47 | -44.11% | -52.13% |
| Sep 11, 2026 | $0.05 | -95.75% | $1.47 | -44.11% | -51.64% |
| Sep 10, 2026 | $0.05 | -95.83% | $1.50 | -42.97% | -52.86% |
| Sep 09, 2026 | $0.05 | -96.08% | $1.55 | -41.06% | -55.02% |
| Sep 08, 2026 | $0.04 | -96.42% | $1.59 | -39.54% | -56.88% |
| Sep 04, 2026 | $0.07 | -93.84% | $1.54 | -41.44% | -52.40% |
| Sep 03, 2026 | $0.12 | -90.17% | $1.54 | -41.44% | -48.73% |
| Sep 02, 2026 | $0.11 | -91.08% | $1.49 | -43.35% | -47.73% |
| Sep 01, 2026 | $0.14 | -88.58% | $1.50 | -42.97% | -45.61% |
| Aug 31, 2026 | $0.16 | -86.42% | $1.54 | -41.44% | -44.98% |
| Aug 28, 2026 | $0.18 | -84.92% | $1.54 | -41.44% | -43.48% |
| Aug 27, 2026 | $0.72 | -40.08% | $1.60 | -39.16% | -0.92% |
| Aug 26, 2026 | $0.78 | -35.00% | $1.64 | -37.64% | +2.64% |
| Aug 25, 2026 | $0.74 | -38.17% | $1.60 | -39.16% | +0.99% |
| Aug 24, 2026 | $0.76 | -36.58% | $1.57 | -40.30% | +3.72% |
Page 1 of 5